Catalyst Wire Dossier Catalyst Wire Dossier

H2N3 influenza vaccine, adjuvanted

H2N3 influenza vaccine (adjuvanted) · Seqirus
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for H2N3 influenza vaccine, adjuvanted, covering 2025-01-22 to 2025-01-22. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate Immunogenicity, Safety and Tolerability of Adjuvanted and Non-Adjuvanted H2N3 Influenza Vaccines in Adults [Phase 1]

See pricing